Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Life-threatening bacterial disease in humans explained
E.coli make up part of the normal gut flora of cattle and humans

Study suggests E. coli toxin in cattle responsible

A new study, published by scientists at the Moredun Research Institute, University of Edinburgh, Biomathematics and Statistics Scotland and international partners, has shown that a specific toxin produced by naturally-occurring E. coli bacteria help the organism to colonise the intestinal tract of cattle and increase transmission of the organism to other animals in the herd.

Rapid and high levels of expression of the toxin also mean that, when humans are infected, they are more likely to suffer more serious symptoms. These toxin properties help explain the emergence of this human pathogen over the last 40 years.

Escherichia coli (E. coli) is a group of bacteria that make up part of the natural gut flora of healthy humans and some animals. While many strains are harmless, some are known to cause serious disease.

Enterohaemorrhagic E. coli (EHEC) O157 are a subset of E. coli that are present in the gastrointestinal tract of cattle but cause no discernible disease in these animals. However, EHEC O157 excreted in the faeces of infected cattle, can be passed on to humans through exposure to contaminated water, meat or vegetables.

EHEC produce toxins known as Shiga toxins (Stx) of various sub-types. These toxins can cause a variety of diseases in humans by attacking the lining of blood vessels within the body. Clinical signs range from diarrhoea – with or without blood – to more severe and potentially fatal kidney disease. The most dangerous toxin subtype to humans is subtype 2a (Stx2a).

The study investigated the role of Stx2a in colonisation of the cattle gut. It showed that Stx2a plays a critical role in increasing transmission of EHEC O157 between cattle owing to a combination of two factors

  • firstly, Stx2a is produced more rapidly by the bacteria than other Shiga toxins;
  • secondly, Stx2a promotes persistence of the bacteria on cells which line the gastro-intestinal tract of cattle by reducing their turnover rate.

This essentially allows infected cells to survive for longer.; and makes it more likely that the cattle will shed the bacteria in their faeces for longer and at higher levels – thereby increasing the chance that the bacteria can be passed to other cattle in the herd as well as to humans.

Prof David Gally, from the Roslin Institute said: “The study is important as it explains firstly why the Stx2a subtype has become common in E. coli O157 strains – the answer being that it can be produced more rapidly compared to some other Stx subtypes.

“Secondly, our work demonstrates how the toxin can provide an advantage in the animal host, basically by halting the usual turnover of gut cells that would remove adherent E. coli; so the bacteria colonise more easily, persist in the gut and can be excreted at high levels to go onto infect other animals and, possibly, humans”.

The original study was funded by the Food Standards Agency and Food Standards Scotland; and ongoing work between the study partners has developed a vaccine for use in cattle which has recently obtained commercial backing for a field trial.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.